Order Article Reprints

Malyshev AV, Sukhanova IA, Ushakova VM, Zorkina YA, Abramova OV, Morozova AY, Zubkov EA, Mitkin NA, Pavshintsev VV, Doronin II, et al. Peptide LCGA-17 Attenuates Behavioral and Neurochemical Deficits in Rodent Models of PTSD and Depression. Pharmaceuticals. 2022; 15(4):462. https://doi.org/10.3390/ph15040462

Malyshev, Anton V., Iuliia A. Sukhanova, Valeria M. Ushakova, Yana A. Zorkina, Olga V. Abramova, Anna Y. Morozova, Eugene A. Zubkov, Nikita A. Mitkin, Vsevolod V. Pavshintsev, Igor I. Doronin, and et al. 2022. "Peptide LCGA-17 Attenuates Behavioral and Neurochemical Deficits in Rodent Models of PTSD and Depression" Pharmaceuticals 15, no. 4: 462. https://doi.org/10.3390/ph15040462

Malyshev, A. V., Sukhanova, I. A., Ushakova, V. M., Zorkina, Y. A., Abramova, O. V., Morozova, A. Y., Zubkov, E. A., Mitkin, N. A., Pavshintsev, V. V., Doronin, I. I., Gedzun, V. R., Babkin, G. A., Sanchez, S. A., Baker, M. D., & Haile, C. N. (2022). Peptide LCGA-17 Attenuates Behavioral and Neurochemical Deficits in Rodent Models of PTSD and Depression. Pharmaceuticals, 15(4), 462. https://doi.org/10.3390/ph15040462